Company

OVERVIEW

CREJUV BIO is a biopharmaceutical R&D company for the B2B tech licensing.

We license out technologies, not products, for the Aesthetic Botulinum Toxin.

It comes with ready-to-use liquid form in pre-filled syringe.

We will provide an optimized and patented botulinum toxin formulation for aesthetic treatment.

We were approved for the Start-Up Visa Program from Government of Canada in 2019 and founded the company in BC Canada in April 2020.

History

2018

11Built CREJUV Team

2019

04Applied Canada Start-Up Visa Program

10Approved SUV Program from Canada

12Visited to Prepare CL2 Lab. in Vancouver BC

2020

04Established CREJUV BIO Inc. in BC Canada
(#738986132BC0001)

09Start Fundraising for Final 10M USD

2021

01Formulation Patent Pending
(#63133889)